Thomas A. Collet, PhD
Thomas Collet is a serial life sciences entrepreneur with deep drug development expertise. He serves as President, CEO and Director of Bilayer Therapeutics. Dr. Collet has founded and led several life sciences companies including ProNAi Therapeutics (subsequently went public, now Sierra Oncology); Neural Intervention Technologies (subsequently acquired by W.L. Gore); and Rubicon Genomics (subsequently acquired … Read more